ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CING Cingulate Inc

1.10
0.01 (0.92%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 74,532
Bid Price 1.10
Ask Price 1.11
News -
Day High 1.115

Low
1.00

52 Week Range

High
23.798

Day Low 1.08
Company Name Stock Ticker Symbol Market Type
Cingulate Inc CING NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.92% 1.10 19:39:52
Open Price Low Price High Price Close Price Prev Close
1.11 1.08 1.115 1.10 1.09
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
309 74,532 $ 1.10 $ 81,940 - 1.00 - 23.798
Last Trade Time Type Quantity Stock Price Currency
19:58:35 5 $ 1.11 USD

Cingulate Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.03M 937.00k - 0 -17.68M -18.86 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cingulate News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CING Message Board. Create One! See More Posts on CING Message Board See More Message Board Posts

Historical CING Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.101.251.051.14261,3030.000.00%
1 Month1.181.501.031.21263,841-0.08-6.78%
3 Months8.008.481.002.36354,115-6.90-86.25%
6 Months14.0614.9981.005.36896,214-12.96-92.18%
1 Year21.0023.7981.007.85598,112-19.90-94.76%
3 Years100.00103.001.0019.20424,893-98.90-98.90%
5 Years100.00103.001.0019.20424,893-98.90-98.90%

Cingulate Description

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.

Your Recent History

Delayed Upgrade Clock